These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 10327996)

  • 21. Liposomal amphotericin B for leishmaniasis treatment of AIDS patients unresponsive to antimonium compounds.
    Lazanas MC; Tsekes GA; Papandreou S; Harhalakis N; Scandali A; Nikiforakis E; Saroglou G
    AIDS; 1993 Jul; 7(7):1018-9. PubMed ID: 8357549
    [No Abstract]   [Full Text] [Related]  

  • 22. [Visceral childhood leishmaniasis: diagnosis and treatment].
    Prieto Tato LM; La Orden Izquierdo E; Guillén Martín S; Salcedo Lobato E; García Esteban C; García-Bermejo I; Ramos Amador JT
    An Pediatr (Barc); 2010 May; 72(5):347-51. PubMed ID: 20378427
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Novel methods for the encapsulation of meglumine antimoniate into liposomes.
    Frézard F; Michalick MS; Soares CF; Demicheli C
    Braz J Med Biol Res; 2000 Jul; 33(7):841-6. PubMed ID: 10881061
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Three Pediatric Cases of Leishmaniasis with Different Clinical Forms and Treatment Regimens].
    Aydın Teke T; Metin Timur Ö; Gayretli Aydın ZG; Öz N; Bayhan Gİ; Yılmaz N; Mungan M; Tanır G
    Turkiye Parazitol Derg; 2015 Jun; 39(2):147-50. PubMed ID: 26081889
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Visceral leishmaniasis with pericarditis in an HIV-infected patient.
    Mofredj A; Guerin JM; Leibinger F; Masmoudi R
    Scand J Infect Dis; 2002; 34(2):151-3. PubMed ID: 11928856
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Relapse of visceral leishmaniasis in HIV infection. Benefit of amphotericin B].
    Kilani B; Amari L; Belhaj S; Goubontini A; Ben Chaabene T
    Tunis Med; 2004 Mar; 82(3):316-9. PubMed ID: 15382468
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Treatment of kala azar.
    Ozsoylu S
    Lancet; 1996 Jun; 347(9016):1701. PubMed ID: 8642997
    [No Abstract]   [Full Text] [Related]  

  • 28. A 7-month-old girl with fever and bleeding.
    Chaliasos N; Bourantas C; Kritikou E; Lapatsanis P
    Lancet; 1996 Apr; 347(9008):1086. PubMed ID: 8602061
    [No Abstract]   [Full Text] [Related]  

  • 29. Combined liposomal immuno- and chemotherapy of visceral leishmaniasis.
    Everlien H; Hockertz S
    Arzneimittelforschung; 1999 Nov; 49(11):954-61. PubMed ID: 10604050
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Resistance of Leishmania infantum to Glucantime: risk factors and therapeutic management].
    Piarroux R; Garnier JM; Gambarelli F; Dumon H; Kaplanski S; Unal D
    Arch Pediatr; 1996 Apr; 3(4):352-6. PubMed ID: 8762958
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Antimony to Cure Visceral Leishmaniasis Unresponsive to Liposomal Amphotericin B.
    Morizot G; Jouffroy R; Faye A; Chabert P; Belhouari K; Calin R; Charlier C; Miailhes P; Siriez JY; Mouri O; Yera H; Gilquin J; Tubiana R; Lanternier F; Mamzer MF; Legendre C; Peyramond D; Caumes E; Lortholary O; Buffet P
    PLoS Negl Trop Dis; 2016 Jan; 10(1):e0004304. PubMed ID: 26735920
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Glucantime-resistant visceral leishmaniasis in immunocompromised patients.
    Verdejo J; Alvar J; Polo RM; González-Lahoz JM
    Am J Med; 1988 Jul; 85(1):128. PubMed ID: 3389377
    [No Abstract]   [Full Text] [Related]  

  • 33. Acute pancreatitis associated with the administration of meglumine antimonate for the treatment of visceral leishmaniasis.
    de Lalla F; Pellizzer G; Gradoni L; Vespignani M; Franzetti M; Stecca C
    Clin Infect Dis; 1993 May; 16(5):730-1. PubMed ID: 8507769
    [No Abstract]   [Full Text] [Related]  

  • 34. An 8-Year Retrospective Study of Human Visceral Leishmaniasis.
    Barbosa JF; de Figueiredo SM; Lyon S; Caligiorne RB
    Curr Clin Pharmacol; 2016; 11(4):265-269. PubMed ID: 27659611
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Combination therapy with liposomal amphotericin b (ambisome), n-methylglucamine antimoniate (glucantime), and pentamidine isethionate in a refractory visceral leishmaniasis case.
    Gomes MAF; Medeiros LLC; Lobo FPD; Wanderley NRS; Matos APR; Jácome TDN; Monteiro MGL; Luz KG
    Rev Soc Bras Med Trop; 2018; 51(3):393-396. PubMed ID: 29972577
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Mediterranean visceral leishmaniasis in pregnancy.
    Gradoni L; Gaeta GB; Pellizzer G; Maisto A; Scalone A
    Scand J Infect Dis; 1994; 26(5):627-9. PubMed ID: 7855563
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Pediatric visceral leishmaniasis in Western Sicily, Italy: a retrospective analysis of 111 cases.
    Cascio A; Colomba C; Antinori S; Orobello M; Paterson D; Titone L
    Eur J Clin Microbiol Infect Dis; 2002 Apr; 21(4):277-82. PubMed ID: 12072938
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Efficacy and safety of amphotericin B deoxycholate versus N-methylglucamine antimoniate in pediatric visceral leishmaniasis: an open-label, randomized, and controlled pilot trial in Brazil.
    Borges MM; Pranchevicius MC; Noronha EF; Romero GA; Carranza-Tamayo CO
    Rev Soc Bras Med Trop; 2017; 50(1):67-74. PubMed ID: 28327804
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Evolution of serum albumin/globulin ratio after antimonial therapy in canine leishmaniasis.
    Amusategui I; Sainz A; Tesouro MA
    Ann N Y Acad Sci; 1998 Jun; 849():447-9. PubMed ID: 9668510
    [No Abstract]   [Full Text] [Related]  

  • 40. Oral leishmaniasis in an HIV-positive patient caused by two different zymodemes of Leishmania infantum.
    Cortés P; Cardeñosa N; Romaní J; Gállego M; Muñoz C; Barrio JL; Riera C; Portús M
    Trans R Soc Trop Med Hyg; 1997; 91(4):438-9. PubMed ID: 9373646
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.